Laddar...
Programmed cell death-1 and programmed cell death ligand-1 antibodies-induced dysthyroidism
BACKGROUND: Monoclonal antibodies blocking the programmed cell death-1 (PD-1) or its ligand (PD-L1) are a group of immune checkpoints inhibitors (ICIs) with proven antitumor efficacy. However, their use is complicated by immune-related adverse events (irAEs), including endocrine adverse events (eAEs...
Sparad:
| I publikationen: | Endocr Connect |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Bioscientifica Ltd
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5937198/ https://ncbi.nlm.nih.gov/pubmed/29739808 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-18-0079 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|